申请人:Solco Basel AG
公开号:US04952683A1
公开(公告)日:1990-08-28
New compounds of the formula (I)-D and (I)-L as shown in the sheet of formulae are described, for example D- and L-erythro-1-(.beta.-D-glycopyranosyloxy)-3-hydroxy-2-palmitoylamino-4-tran s-octadecene, which exert actions promoting wound healing and cell and tissue regeneration, and can be used therapeutically for the treatment of wounds of any cause. They are prepared in good yield and in a stereochemically homogeneous form from ceramides of the formula (II)-D and/or (II)-L. The process comprises the protection of the 1-hydroxyl group, esterification of the 3-hydroxyl group, elimination of the 1-hydroxyl protective group, reaction with the trifluoroacetimidate or trichloroacetimidate of a 2,3,4,6-tetraacylated D-glucose and elimination of the O-acyl groups. When a D,L-ceramide (II) is used, the esterification of the 3-hydroxyl group is carried out by an optically active acid followed by separation into the diastereomers, or separation into the diastereomers is carried out after the reaction with the D-glucose derivative.
本文描述了一些新的化合物,它们的化学式为(I)-D和(I)-L,例如D-和L-erythro-1-(.beta.-D-葡萄糖苷氧基)-3-羟基-2-棕榈酰胺基-4-反式-十八烷,这些化合物具有促进伤口愈合和细胞组织再生的作用,并可用于治疗任何原因引起的伤口。它们可以从化学式(II)-D和/或(II)-L的鞘氨醇中高产高纯度地制备而成。该过程包括保护1-羟基基团,酯化3-羟基基团,去除1-羟基保护基团,与2,3,4,6-四酰基-D-葡萄糖的三氟乙酸酰亚胺盐或三氯乙酸酰亚胺盐反应,去除O-酰基团。当使用D,L-鞘氨醇(II)时,通过手性酸酯化3-羟基基团,然后将其分离成对映异构体,或在与D-葡萄糖衍生物反应后将其分离成对映异构体。